Friday 15 January
Paris Time Zone
08:15-09:15
Mini-course for residents (practical tips)
Rolando Cimaz and Teresa Giani (Italy)
09:15-09:30
Opening session - Welcome
09:30-11:00
Session 1
Chairs: Véronique Hentgen (France) and Michael Levin (UK)
Plenaries
09:30-10:00
- Epidemiology in Europe and worldwide
Maryam Piram (France)
10:00-10:30
- Genetic studies of Kawasaki Disease toward understanding of the pathogenesis and implementation of precision medicine
Yoshi Onouchi (Japan)
Oral communications
10:30-10:40
- Paediatric multi-system inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki Disease (Kawa-COVID-19): a multicentre cohort
Marie Pouletty (Paris, France), Charlotte Borocco, Naim Ouldali, Marion Caseris, Romain Basmaci, Noemie Lachaume, Philippe Bensaid, Samia Pichard, Hanane Kouider, Guillaume Morelle, Irina Craiu, Corinne Pondarré, Anna Deho, Arielle Maronni, Medhi Oualha, Zahir Amoura, Julien Haroche, Juliette Chommeloux, Fanny Bajolle, Constance Beyler, Stephane Bonacorsi, Guislaine Carcelain, Isabelle Koné-Paut, Brigitte Bader-Meunier, Albert Faye, Ulrich Meinzer, Caroline Galeotti, Isabelle Melki
10:40-10:50
- Sub-weekly cycle uncovers the hidden link of atmospheric pollution to Kawasaki Disease
Xavier Rodó (Barcelona, Spain), Albert Navarro-Gallinad, Tomoko Kojima, Joan Ballester, Sílvia Borràs
10:50-11:00
- Kawasaki shock syndrome in a Canadian Pediatric University Hospital over a period of 24 years
Rocio Gissel Gutierrez Rojas (Quebec, Canada), Lea Kena Mom, Anne Fournier, François Proulx, Nagib Dahdah
11:00-11:30
Break
- Video - CSL Behring: Driven by Our promise
- Video - LFB, a biopharmaceutical compagny specialized in biological medicinal products
Visit CSL Behring meeting room from 11:00 to 11:30
11:30-13:00
Session 2
Chairs: Caroline Galeotti (France) and Taco Kuijpers (Netherlands)
Plenaries
11:30-12:00
- What transcriptomics can tell us abput diagnosis, and pathogenesis of Kawasaki disease
Mike Levin (UK)
12:00-12:30
- Current biomarkers to distinguish Kawasaki disease from infectious disease
Taco Kuijpers (Netherlands)
Oral communications
12:30-12:40
- A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease (KD)
Stanford Shulman, Anne Rowley (Chicago, IL, USA), Susan Baker
12:40-12:50
- Characterization of the nasopharyngeal microbiome in patients with Kawasaki Disease
Judith Sánchez-Manubens (Barcelona, Spain), Desirée Henares, Carmen Muñoz-Almagro, Pedro Brotons De Los Reyes, Natalia Timoneda, Jordi Anton
13:00-14:30
Break
14:30-16:00
Session 3
Chairs: Isabelle Melki (France) and Dirk Foell (Germany)
Oral communications
14:30-14:40
- Autoimmune diseases as non-cardiogenic complication of Kawasaki Disease
Veronika Osterman (Ljubljana, Slovenia), Tanja Avramoska, Maša Bizjak, Gašper Markelj, Marko Pokorn, Tadej Avčin
14:40-14:50
- Serum biomarker profiling among KAWAKINRA study participants identifies differential treatment response groups
Christoph Kessel (Muenster, Germany), Isabelle Koné-Paut, Stéphanie Tellier, Alexandre Belot, Linda Rossi-Semerano, Perrine Dusser, Isabelle Marie, Nadja Boukhedouni, Céline Piedvache, Dirk Foell
14:50-15:00
- Secondary symptoms in Kawasaki Disease
Raphaël Darbon (Blaisy-Bas, France), Magalie Luypaert, Tiphaine Mehaignerie, Samir Ould-Khelifa
Plenaries
15:00-15:30
- Clinical features of classical and non classical forms
Jordi Anton (Spain)
15:30-16:00
- Pitfalls in diagnosis
Jane Burns (USA)
16:00-16:30
Break
16:30-18:00
Session 4
Chairs: Alexandre Belot (France) and Rolando Cimaz (Italy)
Plenaries
16:30-17:00
- Treatment in the Acute Phase: 2017 American Heart Association Guidelines
Jane Newburger (USA)
17:00-17:30
- Treatment in acute phase in Japan
Tohru Kobayashi (Japan)
Oral communications
17:30-17:40
- Longterm vascular investigation indicates alteration of medium- but not large-sized arteries in Kawasaki patients with persistent Coronary artery aneurysms
Miriam König (Munich, Germany), Sarah Walther, Theresa Ullmann, André Jakob, Robert Dalla-Pozza, Nikolaus Haas, Marcus Fischer
17:40-17:50
- RAISE Protocol Improves Outcomes for Kawasaki Disease Patients with Coronary Artery Aneurysms at the Time of Diagnosis
Kevin Friedman (Boston, MA, USA)
17:50-18:00
- Long term follow-up of giant coronary aneurysms of Kawasaki Disease in non-Japanese children cohort
Léa Bergez (Malakoff, France), Sophie Malekzadeh-Milani, Guiti, Damien Bonnet, Fanny Bajolle